Literature DB >> 24004848

Animal models of the serotonin syndrome: a systematic review.

Robert Haberzettl1, Bettina Bert, Heidrun Fink, Meredith A Fox.   

Abstract

The serotonin syndrome (SS) is a potentially life-threatening disorder in humans which is induced by ingestion of an overdose or by combination of two or more serotonin (5-HT)-enhancing drugs. In animals, acute administration of direct and indirect 5-HT agonists also leads to a set of behavioral and autonomic responses. In the current review, we provide an overview of the existing versions of the animal model of the SS. With a focus on studies in rats and mice, we analyze the frequency of behavioral and autonomic responses following administration of 5-HT-enhancing drugs and direct 5-HT agonists administered alone or in combination, and we briefly discuss the receptor mediation of these responses. Considering species differences, we identify a distinct set of behavioral and autonomic responses that are consistently observed following administration of direct and indirect 5-HT agonists. Finally, we discuss the importance of a standardized assessment of SS responses in rodents and the utility of animal models of the SS in translational studies, and provide suggestions for future research.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-HT; 5-HT agonist; 5-HT transporter; 5-HT-enhancing drug; 5-HTP; 5-HTT; 5-hydroxy-l-tryptophan; Animal model; Core response; MAO; MAOA-I; MAOA/B-I; MAOB-I; Mouse; Rat; SNRI; SRI; SS; SSRI; Serotonin; Serotonin syndrome; TCA; Validity; monoamine oxidase; monoamine oxidase type A inhibitor; monoamine oxidase type A/B inhibitor; selective serotonin reuptake inhibitor; serotonin; serotonin reuptake inhibitor; serotonin syndrome; serotonin/norepinephrine reuptake inhibitor; tricyclic antidepressant

Mesh:

Substances:

Year:  2013        PMID: 24004848     DOI: 10.1016/j.bbr.2013.08.045

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  25 in total

1.  Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans.

Authors:  Hideaki Yano; Pramisha Adhikari; Sett Naing; Alexander F Hoffman; Michael H Baumann; Carl R Lupica; Lei Shi
Journal:  ACS Chem Neurosci       Date:  2020-04-30       Impact factor: 4.418

2.  Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Neuropharmacology       Date:  2015-02       Impact factor: 5.250

3.  [Age 89 years, depression, fall with pelvic fracture, severe confusion - serotonin syndrome : Differential diagnosis, importance of CYP450 and economic considerations].

Authors:  W Weinrebe; A Moutaouakil; K Risz; M Martin; K Jeckelmann; S Goetz
Journal:  Z Gerontol Geriatr       Date:  2017-04-18       Impact factor: 1.281

4.  Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Pharmacol Rep       Date:  2016-02-05       Impact factor: 3.024

Review 5.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 6.  Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Authors:  Kathryn Lanza; Christopher Bishop
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

7.  Directly Observable Behavioral Effects of Lorcaserin in Rats.

Authors:  Katherine M Serafine; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2015-09-17       Impact factor: 4.030

8.  Effects of fentanyl on serotonin syndrome-like behaviors in rats.

Authors:  Sonoe Kitamura; Takashi Kawano; Satomi Kaminaga; Daiki Yamanaka; Hiroki Tateiwa; Fabricio M Locatelli; Masataka Yokoyama
Journal:  J Anesth       Date:  2015-10-26       Impact factor: 2.078

9.  Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems.

Authors:  María Teresa Rivera-García; Carolina López-Rubalcava; Silvia L Cruz
Journal:  Psychopharmacology (Berl)       Date:  2015-08-09       Impact factor: 4.530

10.  Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.

Authors:  D Lindenbach; N Palumbo; C Y Ostock; N Vilceus; M M Conti; C Bishop
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.